News
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Scientists use patient-derived breast cancer organoids—or 3D mini-tumors—to study processes involved in slowing or stopping tumor growth, also known as cellular senescence.
The therapeutic landscape for hormone receptor-positive (HR+) advanced breast cancer (BC) is moving from generalized ...
Imagion Biosystems (ASX: IBX) has announced it will fast-track a new batch of MagSense HER2 imaging agent ahead of a Phase 2 ...
Dr. Erika Hamilton discusses the most notable breast cancer treatments currently in development, and how might they change care for patients in the future.
Oncopathology or cancer pathology is a specialised branch of pathology focused on diagnosing and characterising tumours ...
DCIS is a non-invasive or pre-invasive breast cancer, meaning the cancer cells are confined to the milk ducts and haven’t ...
Onlymyhealth on MSN4d
Olivia Munn’s Mom Diagnosed With HER2 Breast Cancer, Credits Risk Assessment Test for Early DiagnosisOlivia Munn has come a long way with her personal experience of breast cancer. Having informed the world of her diagnosis in ...
Health and Me on MSN5d
Olivia Munn’s Mom Diagnosed With Breast Cancer After Actor Urges Her To Take Risk Test; What Should You Do If It Runs In Your Family?Olivia Munn revealed her mother was diagnosed with Stage 1 HER2 breast cancer after taking the same risk assessment test that helped detect Munn’s own cancer, prompting early MRI screening.
USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, July 10, 2025 /PRNewswire/ -- USA News Group News Commentary - Cancer rates are rising everywhere ...
The update strengthens IBTROZI's position as a next-generation treatment in a rare, aggressive lung cancer that often spreads ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback